Objective
=========

To assess the value of measuring serum levels of soluble intercellular adhesion molecule 1 (sICAM-1) in systemic lupus erythematosus (SLE).

Material and methods
====================

We studied 35 patients (pts) (7 female, 28 male), satisfying the ACR criteria for SLE. Mean age of pts was 31,4 ± 12,0 years (range 17-63), mean disease duration was 81,8 ± 70,5 month (range 2-240). Disease activity was assessed by disease activity indices (SLAM, SLEDAI). Enzyme-linked immunosorbent assay was used to measure levels of sICAM-1 (R\$D, USA). The results were compared with 18 healthy subjects.

Results
=======

Levels of sICAM-1 were found elevated (more than 2 SD above the mean in normal controls, 443 ng/ml) in 7 of 35 (20%) pts with SLE. The relations between positive sICAM-1 and some clinical manifestations of SLE have been detected. We found significant correlation between individual sICAM-1 serum level and the SLEDAI (r=043) and SLAM (r=0,56) scores, and ESR (r=0,53).

Conclusion
==========

Elevated serum levels of sICAM-1 can be found in SLE and correlate with disease activity. Longitudinal studies may establish their clinical value in the monitoring or the prognosis of patients.

  Parameters,       Positive sICAM-1   Negative sICAM-1   
  ----------------- ------------------ ------------------ ---------
  ICAM-1, ng/ml     512,3 ± 45,5       284,3 ± 85,0       \<0,001
  Malar rash        28,6%              14,2%              NS
  arthritis         42,8%              25%                NS
  nephritis         57,2%              32,1%              NS
  CNS involvement   71,4%              39,3%              NS
  Serositis         42,8%              14,3%              NS
  ESR, mm/h         38,0 ± 24,8        21,2 ± 16,1        \<0,05
  SLAM, score       16,0 ± 7,4         9,03 ± 5,7         \<0,05
  SLEDAI, score     18,0 ± 12,4        10,2 ± 7,75        \<0,05
